Literature DB >> 19118505

Generation and regulation of CD8(+) regulatory T cells.

Linrong Lu1, Harvey Cantor.   

Abstract

Research into the suppressive activity of CD4(+)FoxP3(+) T regulatory cells (Treg) has defined a sublineage of CD4(+) cells that contribute to self-tolerance and resistance to autoimmune disease. Much less attention has been given to the potential contribution of regulatory sublineages of CD8(+) cells. Analysis of a small fraction of CD8(+) cells that target autoreactive CD4(+) cells through recognition of the MHC class Ib molecule Qa-1 in mouse and HLA-E in human has revitalized interest in CD8(+) Treg. Here we summarize recent progress and future directions of research into the role of this CD8(+) sublineage in resistance to autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118505      PMCID: PMC4072402          DOI: 10.1038/cmi.2008.50

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  38 in total

Review 1.  Mechanisms of self-nonself discrimination and possible clinical relevance.

Authors:  Carolin Daniel; Jens Nolting; Harald von Boehmer
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

2.  Comeback kids: CD8(+) suppressor T cells are back in the game.

Authors:  Luc Van Kaer
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

3.  The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism.

Authors:  Sourojit Bhowmick; Anurag Singh; Richard A Flavell; Robert B Clark; James O'Rourke; Robert E Cone
Journal:  J Leukoc Biol       Date:  2009-09-09       Impact factor: 4.962

4.  CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.

Authors:  Li Ma; Elisa Simpson; June Li; Min Xuan; Miao Xu; Laura Baker; Yan Shi; Issaka Yougbaré; Xiaozhong Wang; Guangheng Zhu; Pingguo Chen; Gerald J Prud'homme; Alan H Lazarus; John Freedman; Heyu Ni
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

Review 5.  Immune regulation of multiple sclerosis by CD8+ T cells.

Authors:  Sushmita Sinha; Farah R Itani; Nitin J Karandikar
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis.

Authors:  Crisol Álvarez-Quiroga; Carlos Abud-Mendoza; Lesly Doníz-Padilla; Amida Juárez-Reyes; Adriana Monsiváis-Urenda; Lourdes Baranda; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2011-04-13       Impact factor: 8.317

7.  Generation of Regulatory T Cells to Antigen Expressed in the Retina.

Authors:  Scott W McPherson; Neal D Heuss; Ute Lehman; Dale S Gregerson
Journal:  Curr Immunol Rev       Date:  2011

8.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

Review 9.  Lymphocytes in cancer development: polarization towards pro-tumor immunity.

Authors:  Brian Ruffell; David G DeNardo; Nesrine I Affara; Lisa M Coussens
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-11       Impact factor: 7.638

10.  CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells.

Authors:  Nora Manzke; Ilseyar Akhmetzyanova; Kim J Hasenkrug; Mirko Trilling; Gennadiy Zelinskyy; Ulf Dittmer
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.